This randomized clinical trial compares the efficacy of intensive glucose management, which included use of an automated insulin delivery system, vs standard care, which included use of a continuous glucose monitor, to achieve near normalization of glucose levels to preserve pancreatic β cell function in youths with newly diagnosed type 1 diabetes.
Source: JAMA Online First